Hindustan Unilever Ltd. share price target

However, over the medium term we believe, HUVR has the right growth matrix like 1) broad based portfolio straddling across price-value matrix, 2) focus on cost savings 3) GSK-CH integration led tailwinds, 4) execution prowess vs peers and 5) strong data analytics capabilities. We maintain BUY rating

GTM integration for nutrition business at 85% mark We are cutting FY22/23 EPS by 1.9%/0.2% on the back of 1) Inflationary environment impacting GRMs and 2) Slowdown witnessed in rural demand neutralized partly by uptick in Discretionary segments. Despite the near term inflation challenges, we remain positive on the structural story given that 1)...

While commodity costs remain elevated, we believe mix improvement would lead to continued sequential margin improvement. HUVR's share of the Discretionary and Out-of-Home (OOH) portfolios (~15% of sales) is higher v/s peers. Moreover, these businesses have much higher margins than the rest of the portfolio. As a result, the earnings growth outlook from 2HFY22 is incrementally better v/s peers....

We expect HUVR to witness MoM improvement in demand since June-21 Change in Estimates | Target | Reco aided by resilient Rural demand and improving Urban demand. Inflation in Palmoil and Crude is likely to pressurize margins, however the intensity will...

We marginally revise our FY23E/24E and maintain BUY with a revised TP of Rs. 3,100 (earlier Rs. 2,670) as we raise our target PE to 56x FY24E EPS (earlier 50x FY24E EPS).

We attended HUVR's analyst meet where the management sounded positive on the future growth potential and achieving competitive growth backed by Change in Estimates | Target | Reco 1) category leading position in ~80% of its portfolio 2) market development in...

The management shared details on the augmentation of its analytics and R&D; strengths, which were already far superior v/s peers. As highlighted in our Annual Report note, there have been a host of initiatives in the past year focusing on the burgeoning E-Commerce market, which now contributes 89% to HUVR's sales. The company's portfolio is already wellplaced, with its E-Commerce market share higher than its Modern Trade (MT)...

While our long-term outlook remains positive, we expect margins to remain under pressure in the near-term, unless the company manages further price hikes. The stock is trading at expensive valuations. Given limited upside to current price level, we downgrade our rating to HOLD with a revised TP of Rs. 2,540 based on 54x FY23E adj. EPS. Volume growth aids topline on YoY basis Company's Q1FY22 standalone revenue came in at Rs. 11,915cr (+12.8% YoY, -1.8% QoQ) aided by volume growth on improved consumer demand, despite disruptions...

ended June 2021 has increased 14% to Rs 12194 crore. Operating profit margin has slumped from 25.1% to 24%, leading to 8% rise in operating profit to Rs 2,921.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 33.79% to 30.51%. Purchase of finished goods cost rose from 15.15% to 18.51%. Employee cost decreased from 5.72% to 5.42%. Other expenses rose from 20.62% to 21.34%. Selling and administration expenses rose from 7.34% to 8.53%. Other income fell 57% to Rs 66 crore. Provision for interest fell 58% to Rs 13 crore. Provision for depreciation rose 1% to Rs 260 crore. Profit...

Consequent PAT was at | 2061 crore (up 9.6% YoY) five years (from ~| 922 in July 2016 to ~| 2388 levels in July 2021). We roll over FY24 numbers given Covid-19 related disruptions have temporarily impacted financials & FY23-FY4 would be a normalised year. We continue to remain positive and retain our BUY rating on the stock...